SYRE 240920 40.00P (SYRE240920P40000) Stock Options, News & Quotes

US OptionsDetailed Quotes

SYRE240920P40000

Watchlist

13.20
0.000.00%

15min DelayClose Sep 16 15:59 ET

0.00High0.00Low

Intraday

5D
Daily

News

Spyre Therapeutics to Participate in Upcoming Investor Conference
PR NewswireSep 10 16:47 ET
Spyre Therapeutics Files for $500M Mixed Securities Shelf
Seeking AlphaSep 6 16:26 ET
Express News | Spartan Resources Ltd Files for Mixed Shelf of up to $500 Mln - SEC Filing
ReutersSep 6 16:07 ET
Spyre Therapeutics Initiated at Outperform by Wedbush
Dow JonesSep 4 11:35 ET · Ratings
Wedbush Initiates Spyre Therapeutics(SYRE.US) With Buy Rating, Announces Target Price $45
Moomoo NewsSep 3 17:31 ET · Ratings
Buy Recommendation for Spyre Therapeutics Based on Promising IBD Pipeline and Strong Financial Position
TipRanksAug 9 07:01 ET

Comments

108S

Jun 11 11:15

$Spyre Therapeutics (SYRE.US)$ will it rise?

Rocketier

May 29 13:03

$Spyre Therapeutics (SYRE.US)$ it's seems like the past mp ranged around 100-300, but not sure why there's a sudden huge crash in price. Do u guys think it can get back to the past price?

Moomoo Recap US

Jan 22 15:13

Columns Wall Street Street | Great Day For Volume Stocks on Fresh Index Records

RECAP
U.S. stocks advanced on Monday, building off a record finish ahead of the ramping up of fourth-quarter earnings season.
The $Dow Jones Industrial Average (.DJI.US)$ rose 138 points, or 0.26%, to 38,000. The $S&P 500 Index (.SPX.US)$ was up 10 points, or 0.22%, at 4,850. The $Nasdaq Composite Index (.IXIC.US)$advanced 49 points, or 0.32%, to 15,360.
While the S&P 500 finally returned to record territory on Friday, skeptic...

Kevin Travers

Jan 22 09:51

Columns BiotTech Rises with the Index Tide

After two major indexes reached all-time highs, pharmaceutical stocks for companies in drug trials were caught up in the energy and rocketed forward. The largest gainers were $Spyre Therapeutics (SYRE.US)$, up 26% Monday morning, and $Gyre Therapeutics (GYRE.US)$ +10%.
Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel. $Ginkgo Bioworks (DNA.US)$ also roase 9%, despite a new sell rating from Goldman Sachs.
But monday morning was not al...

AmyNic

Nov 28, 2023 13:56

Halted

$Spyre Therapeutics (SYRE.US)$